Pessary discontinuation rate

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery

31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptom

Effect: adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery